Previous Close | 17.7 |
1-Year Change | -55.05% |
6-Months Change | -15.79% |
3-Months Change | -4.17% |
Moving Avg (50d) | 17.616 |
Moving Avg (200d) | 21.908 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 434.7M |
Beta (3-Years) | 0.61 |
Revenue Growth (ttm) | -1.98% |
Net Profit Margin (ttm) | 19.33% |
Return On Assets (ttm) | 23.93% |
EPS (ttm) | 1.16 |
PE Ratio (ttm) | 15.26 |
Dividend Yield | 7.68% |
Asset Description: | National Research Corporation |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
18.054 | 18.585 | 18.939 | 19.47 | 20.355 | 21.24 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |